The expression of Major Histocompatibility Complex class II (MHC II) molecules on tumour cells has emerged as a critical determinant of antitumour immunity. Conventionally restricted to professional ...

In a paradigm-breaking study, researchers have discovered a novel way the immune system, specifically T cells, attack their target cells, reshaping long-held assumptions in immunology and ...

A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to ...

Schematic illustration of nanomaterial-mediated modulation of the cancer immunity cycle. This schematic illustrates the core strategies of nanomaterials in systematically enhancing cancer ...

The adaptive immune system is an antigen-specific structure that discriminates non-self molecules through the recognition of peptide antigens using receptor interactions between T-cells and ...

In a paradigm breaking study, Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM) and his team, in collaboration with Drs. Arul Chinnaiyan, S ...